Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

By sjmartinez • May 13, 2025

Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton LM, Massimino L, Neurath M, Allez M, Atreya R, Snapper SB, Raine T, Ahuja V, Haberman Y, Feagan BG, Jairath V, Vande Casteele N. Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials. J Crohns Colitis. 2025 May 8;19(5):jjaf068. doi: 10.1093/ecco-jcc/jjaf068. PMID: 40295219.

Tags: Cedars Sinai DoM, clinical trials, Digestive Diseases, inflammatory bowel disease, Publications, transcriptomic analysis

AI-CVD-AF: A Novel Atrial Fibrillation Prediction Model Based on Coronary Artery Calcium Scans

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, Fan[...]

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies

Barry J, Abranches E, Baptista RP, Barry C, Brandsten C, Bruce K, Carpenter MK, Cavagnaro J, Collins L, Csaszar E, Dashnau J, de Villa D,[...]